Ana Petrovic
Osijek, 31000, Croatia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Correction: Knezović et al. Drug Pipeline for MASLD: What Can Be Learned from the Successful Story of Resmetirom. Curr. Issues Mol. Biol. 2025, 47, 154.
Journal: Current issues in molecular biology
Published: November 14, 2025
Advances in Precision Oncology: From Molecular Profiling to Regulatory-Approved Targeted Therapies.
Journal: Cancers
Published: September 25, 2025
Structural hybridization as a tool for developing novel biologically active analogues of protulactone A.
Journal: Bioorganic chemistry
Published: September 22, 2025
Drug Pipeline for MASLD: What Can Be Learned from the Successful Story of Resmetirom.
Journal: Current issues in molecular biology
Published: February 02, 2025
Stabilization Splint Therapy for Patients with Temporomandibular Disorders Improves Opening Movements and Jaw Limitation and Attenuates Pain by Influencing the Levels of IL-7, IL-8, and IL-13 in the Gingival Crevicular Fluid.
Journal: Medicina (Kaunas, Lithuania)
Published: January 07, 2025
Green Tea Polyphenol (-)-Epicatechin Pretreatment Mitigates Hepatic Steatosis in an In Vitro MASLD Model.
Journal: Current issues in molecular biology
Published: July 11, 2024
MAFLD Pandemic: Updates in Pharmacotherapeutic Approach Development.
Journal: Current issues in molecular biology
Published: May 29, 2024
Changes in Dickkopf-1, but Not Sclerostin, in Gingival Crevicular Fluid Are Associated with Peroral Statin Treatment in Patients with Periodontitis.
Journal: Medicina (Kaunas, Lithuania)
Published: February 01, 2024
Monoclonal IgY antibodies: advancements and limitations for immunodiagnosis and immunotherapy applications.
Journal: Therapeutic advances in vaccines and immunotherapy
Published: November 30, 2023
Future Prospects, Approaches, and the Government's Role in the Development of a Hepatitis C Virus Vaccine.
Journal: Pathogens (Basel, Switzerland)
Published: October 31, 2023
Biomarkers for Assessing Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus on Sodium-Glucose Cotransporter 2 Inhibitor Therapy.
Journal: Journal of clinical medicine
Published: September 15, 2023
Last Updated: 09/26/2026